A landmark 10-year randomized controlled trial led by researchers at the Rush Alzheimer's Disease Center in Chicago has found that a combination of five modifiable lifestyle changes reduces the risk of developing dementia by 45% in Americans over 60. The study, involving 3,500 participants, is the largest dementia prevention trial ever conducted in the United States and offers the first rigorous evidence that Alzheimer's risk is meaningfully modifiable.
The five interventions that produced the risk reduction: regular aerobic exercise (150 minutes per week), a Mediterranean-DASH diet emphasizing whole grains, leafy greens, fish, and nuts, cognitive engagement (learning new skills, complex reading, social interaction), quality sleep (7-8 hours with sleep apnea treated if present), and stress management through mindfulness or therapy.
The 45% risk reduction was consistent across income, education, and racial groups when participants adhered to all five components. Adherence to just three of the five components produced a 28% reduction, suggesting that partial adherence is still substantially beneficial.
With 6.7 million Americans currently living with Alzheimer's β a number projected to reach 14 million by 2050 β even a 45% reduction in incidence would prevent millions of cases and save trillions in care costs. The Alzheimer's Association has called the findings "the most significant development in dementia prevention since the field began."
